25 years of biotech operations. From incubator to first-in-human.
Kriyagen Partners embeds senior CMC and regulatory leadership inside early-stage biotech companies to get programs to the clinic.
Leadership experience across:
How We Work
We work inside your company as embedded operational leadership. CMC strategy and IND readiness, CDMO selection and contract negotiation, process development oversight from upstream through fill-finish, regulatory pathway planning, and building the teams your program needs. We do not hand you a deliverable and leave. We stay until the work is done.
When You Need Us.
You have a molecule but no CMC plan
Your science is strong. You do not have a regulatory or manufacturing strategy to get it to the clinic.
You are selecting a CDMO for the first time
You need to choose the right manufacturing partner and negotiate a contract you will not regret in 18 months.
You need to file an IND and the clock is running
You have a timeline, investor expectations, and no operational leadership to drive the submission.
You need a regulatory team but cannot hire full-time yet
You need executive-level operations now, before your headcount budget catches up.
Our Leader
Dr. Dinesh Raturi, MD
Built a recombinant protein program from an empty lab to first-in-human trials in under five years as VP of Operations at Klotho Therapeutics. Led every CMC activity from cell line development through IND submission. Selected and managed CDMOs across three continents. Co-inventor on five published patents.
25 years spanning bench science to C-suite operations across monoclonal antibodies, fusion proteins, biosimilars, and small molecules.